Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis.

Pili R, Kruszewski MP, Hager BW, Lantz J, Carducci MA.

Cancer Res. 2001 Feb 15;61(4):1477-85.

2.

Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.

Verheul HM, Qian DZ, Carducci MA, Pili R.

Cancer Chemother Pharmacol. 2007 Aug;60(3):329-39. Epub 2007 Jan 26.

PMID:
17256134
3.

Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanoma.

Kato Y, Salumbides BC, Wang XF, Qian DZ, Williams S, Wei Y, Sanni TB, Atadja P, Pili R.

Mol Cancer Ther. 2007 Jan;6(1):70-81.

4.

Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.

Melchior SW, Brown LG, Figg WD, Quinn JE, Santucci RA, Brunner J, Thüroff JW, Lange PH, Vessella RL.

Int J Oncol. 1999 Mar;14(3):501-8.

PMID:
10024683
7.

In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.

Qian DZ, Ren M, Wei Y, Wang X, van de Geijn F, Rasmussen C, Nakanishi O, Sacchi N, Pili R.

Prostate. 2005 Jun 15;64(1):20-8.

PMID:
15651062
8.

Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.

Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK.

J Nutr. 1999 Sep;129(9):1628-35.

9.

[Combination of phenylbutyrate and 5-Aza-2'deoxycytidine inhibits human Kasumi-1 xenograft tumor growth in nude mice].

Hao CL, Lin D, Wang LH, Xing HY, Wang M, Wang JX.

Zhonghua Xue Ye Xue Za Zhi. 2004 Nov;25(11):658-61. Chinese.

PMID:
15634569
10.

Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts.

Williams S, Pettaway C, Song R, Papandreou C, Logothetis C, McConkey DJ.

Mol Cancer Ther. 2003 Sep;2(9):835-43.

11.

Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.

Shalinsky DR, Bischoff ED, Gregory ML, Gottardis MM, Hayes JS, Lamph WW, Heyman RA, Shirley MA, Cooke TA, Davies PJ, et al.

Cancer Res. 1995 Jul 15;55(14):3183-91.

12.

Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma.

Rosanò L, Spinella F, Salani D, Di Castro V, Venuti A, Nicotra MR, Natali PG, Bagnato A.

Cancer Res. 2003 May 15;63(10):2447-53.

13.
15.
16.
18.

Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.

Hoffmann S, Rockenstein A, Ramaswamy A, Celik I, Wunderlich A, Lingelbach S, Hofbauer LC, Zielke A.

Mol Cell Endocrinol. 2007 Jan 29;264(1-2):74-81. Epub 2006 Nov 13.

PMID:
17101211
19.

Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.

Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.

Clin Cancer Res. 2008 Apr 1;14(7):2210-9. doi: 10.1158/1078-0432.CCR-07-1893.

20.

Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.

Svechnikova I, Gray SG, Kundrotiene J, Ponthan F, Kogner P, Ekström TJ.

Int J Oncol. 2003 Mar;22(3):579-88.

PMID:
12579311

Supplemental Content

Support Center